Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 689-699 , March 2010

Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia

Presented at the Society for Vascular Surgery (SVS) Research Initiatives Conference, March 2006, Washington, DC, and the SVS Research Initiatives Conference, March 2007, Washington, DC.

  • Teik K. Ho, MRCS, PhD

      Affiliations

    • Vascular Unit, University Department of Surgery, London, United Kingdom
    • Corresponding Author InformationReprint requests: Teik K. Ho, MRCS, PhD, Vascular Unit, Department of Surgery, The Royal Free and University College Medical School, University College London (Hampstead Campus), The Royal Free Hospital, Pond Street, London NW3 2QG
    • ,
  • Janice Tsui, MD, FRCS

      Affiliations

    • Vascular Unit, University Department of Surgery, London, United Kingdom
    • ,
  • Shiwen Xu, PhD

      Affiliations

    • Centre for Rheumatology, The Royal Free and University College Medical School, University College London (Hampstead Campus), London, United Kingdom
    • ,
  • Patricia Leoni, PhD

      Affiliations

    • Centre for Rheumatology, The Royal Free and University College Medical School, University College London (Hampstead Campus), London, United Kingdom
    • ,
  • David J. Abraham, PhD

      Affiliations

    • Centre for Rheumatology, The Royal Free and University College Medical School, University College London (Hampstead Campus), London, United Kingdom
    • ,
  • Daryll M. Baker, PhD, FRCS

      Affiliations

    • Vascular Unit, University Department of Surgery, London, United Kingdom

Received 10 May 2009 ,Accepted 4 October 2009.

References 

  1. Novo S, Coppola G, Milio G. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4:219–225
  2. Ho TK, Rajkumar V, Black CM, Abraham DJ, Baker DM. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischemia. Br J Surg. 2006;93:1368–1376
  3. Ho TK, Rajkumar V, Ponticos M, Leoni P, Black DC, Abraham DJ, et al. Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia. J Vasc Surg. 2006;43:125–133
  4. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 2005;15:57–63
  5. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res. 2000;6:3530–3535
  6. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005;65:465–472
  7. Nagasawa T, Tachibana K, Kawabata K. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv Immunol. 1999;71:211–228
  8. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 1995;28:495–500
  9. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 2001;12:313–335
  10. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998;273:23169–23175
  11. Han Y, Wang J, He T, Ransohoff RM. TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res. 2001;888:1–10
  12. Popik W, Hesselgesser JE, Pitha PM. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol. 1998;72:6406–6413
  13. Sotsios Y, Whittaker GC, Westwick J, Ward SG. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol. 1999;163:5954–5963
  14. Murdoch C, Monk PN, Finn A. Cxc chemokine receptor expression on human endothelial cells. Cytokine. 1999;11:704–712
  15. Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis. 2004;32:52–57
  16. Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells. 2003;21:363–371
  17. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003;198:1391–1402
  18. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumeur suppressor pVHL. Nature. 2003;425:307–311
  19. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 1992;99:683–690
  20. Kamal K, Du W, Mills I, Sumpio BE. Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem. 1998;71:491–501
  21. Oliver MH, Harrison NK, Bishop JE, Cole PJ, Laurent GJ. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci. 1989;92(Pt 3):513–518
  22. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322–1328
  23. Beckert S, Farrahi F, Aslam RS, Scheuenstuhl H, Königrainer A, Hussain MZ, et al. Lactate stimulates endothelial cell migration. Wound Repair Regen. 2006;14:321–324
  24. Xu SW, Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR, et al. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem. 2004;279:23098–23103
  25. Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol. 2005;15:378–386
  26. Ponce ML, Nomizu M, Delgado MC, Kuratomi Y, Hoffman MP, Powell S, et al. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ Res. 1999;84:688–694
  27. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187–195
  28. Sobieszek A, Small JV. Effect of muscle and non-muscle tropomyosins in reconstituted skeletal muscle actomyosin. Eur J Biochem. 1981;118:533–539
  29. De la Luz SM, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood. 2004;103:2452–2459
  30. Altenburg JD, Broxmeyer HE, Jin Q, Cooper S, Basu S, Alkhatib G. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities. J Virol. 2007;81:8140–8148
  31. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Renzana-Seisdedos F, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997;16:6996–7007
  32. Cuthbertson RA, Hopper JL, Mandel TE. Difference in effect of cultured fetal pancreas transplants on retinal and renal capillary basement membrane thickness in diabetic mice. Transplantation. 1989;48:218–223
  33. Naeser P, Swenne I. Labelling of retinal capillaries in mice by repeated [3H]thymidine injections. Acta Ophthalmol (Copenh). 1986;64:9–11
  34. Wickline KM, Fischer VW. Incorporation of [3H]thymidine into myocardial capillary cells in streptozotocin-diabetic rats. Exp Mol Pathol. 1985;43:135–141
  35. Maurer HR. Potential pitfalls of [3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet. 1981;14:111–120
  36. Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol. 2002;169:5546–5554
  37. De PB, De Bleecker JL. Beta-chemokine receptor expression in idiopathic inflammatory myopathies. Muscle Nerve. 2005;31:621–627
  38. Sasaki T, Fukazawa R, Ogawa S, Kanno S, Nitta T, Ochi M, et al. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int. 2007;49:966–971
  39. Cipriani P, Franca MA, Liakouli V, Pacini A, Manetti M, Marrelli A, et al. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum. 2006;54:3022–3033
  40. Carr AN, Howard BW, Yang HT, Eby-Wilkens E, Loos P, Varbanov A, et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res. 2006;69:925–935

 Supported by the Circulation Foundation, United Kingdom.

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)02094-1

doi: 10.1016/j.jvs.2009.10.044

Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 689-699 , March 2010

Article Tools

* Image Usage & Resolution